[Elsevier] Lipidation-dimerization platform unlocks treatment potential of fibroblast growth factor 21 for non-alcoholic steatohepatitis |
|
This post will be closed automatically in 2026-08-28 17:36
Reward10points
|
10
A novel 2D bismuthene-molybdenum disulfide nanocomposite for high energy density supercapacitors and fabrication scaled to pouch cell
10
Lipidation-dimerization platform unlocks treatment potential of fibroblast growth factor 21 for non-alcoholic steatohepatitis
10
Radiation shielding properties of glass composition
10
Diagnostic discordance between planar and single photon emission computed tomography cardiac scintigraphy for transthyretin cardiac amyloidosis
10
The impact of green innovations on firm＊s sustainable operations: Process innovation and recycling innovation
